Francis Ndungu/Wellcome Open Res
3 results
TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults).Abouyannis, M.
FitzGerald, R.
Ngama, M.
Mwangudzah, H.
Nyambura, Y. K.
Ngome, S.
Riako, D.
Babu, L.
Lewa, F.
Else, L.
Dily Penchala, S.
Orindi, B.
Mumba, N.
Kalama, B.
Ndungu, F. M.
Adetifa, I.
Khoo, S.
Lalloo, D. G.
Casewell, N. R.
Hamaluba, M.
Wellcome Open Res, (2022). 7:90
10-year longitudinal study of malaria in children: Insights into acquisition and maintenance of naturally acquired immunity.Addy, J. W. G.
Bediako, Y.
Ndungu, F. M.
Valetta, J. J.
Reid, A. J.
Mwacharo, J.
Ngoi, J. M.
Wambua, J.
Otieno, E.
Musyoki, J.
Said, K.
Berriman, M.
Marsh, K.
Bejon, P.
Recker, M.
Langhorne, J.
Wellcome Open Res, (2022). 6:79
A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 (E) on blood stage immunity in young Kenyan children.Ndungu, F. M.
Mwacharo, J.
Wambua, J.
Njuguna, P.
Marsh, K.
Drakeley, C.
Bejon, P.
Wellcome Open Res, (2019). 4:42